Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2020 How Should Clinicians Respond to International Public Health Emergencies? Abbey Lowe, MA, Angela Hewlett, MD, MS, and Toby Schonfeld, PhD Balancing need for global solidarity against local stakeholders’ safety concerns is one source of tension when trying to mitigate global risk. AMA J Ethics. 2020;22(1):E16-21. doi: 10.1001/amajethics.2020.16. Case and Commentary May 2021 Should Needlestick Protocols Influence Documentation or Disclosure of a Patient’s HIV Status? Shaoli Chaudhuri, MD, MPH, Raaka Kumbhakar, MD, and Ellen Morrison, MD, MPH Heightened privacy and confidentiality stakes generate unique anonymity and nondisclosure policies and practices for HIV. AMA J Ethics. 2021;23(5):E376-381. doi: 10.1001/amajethics.2021.376. Case and Commentary May 2021 How Should Clinicians Respond if Patient HIV Denial Could Exacerbate Racial Health Inequities? Tim Lahey, MD, MMSc Deception’s justifiability might depend on clinicians’ commitment to solidarity and awareness of social determinants of patients’ vulnerability to HIV infection. AMA J Ethics. 2021;23(5):E382-387. doi: 10.1001/amajethics.2021.382. Case and Commentary May 2021 Should Patients Who Receive Postexposure Prophylaxis After Sexual Assault Be Considered for Preexposure Prophylaxis for HIV? Michela Blain, MD and Julia C. Dombrowski, MD, MPH Patient-centered care means offering potentially beneficial interventions while avoiding retraumatizing a patient. AMA J Ethics. 2021;23(5):E388-393. doi: 10.1001/amajethics.2021.388. AMA Code Says May 2021 AMA Code of Medical Ethics’ Opinions Related to “Ending the HIV Epidemic: A Plan for America” Robert Dinallo The AMA Code of Medical Ethics offers guidance on HIV screening that expresses respect for patient autonomy while protecting public health. AMA J Ethics. 2021;23(5):E402-404. doi: 10.1001/amajethics.2021.402. Case and Commentary Apr 2006 Changing the Rules in Times of Crisis: Do Desperate Times Allow Desperate Measures? Mona Loutfy, MD, MPH Clinical case examines the ethics of using an experimental drug in treating a patient who is dying from a SARS-like virus. Virtual Mentor. 2006;8(4):214-218. doi: 10.1001/virtualmentor.2006.8.4.ccas4-0604.
Case and Commentary Jan 2020 How Should Clinicians Respond to International Public Health Emergencies? Abbey Lowe, MA, Angela Hewlett, MD, MS, and Toby Schonfeld, PhD Balancing need for global solidarity against local stakeholders’ safety concerns is one source of tension when trying to mitigate global risk. AMA J Ethics. 2020;22(1):E16-21. doi: 10.1001/amajethics.2020.16.
Case and Commentary May 2021 Should Needlestick Protocols Influence Documentation or Disclosure of a Patient’s HIV Status? Shaoli Chaudhuri, MD, MPH, Raaka Kumbhakar, MD, and Ellen Morrison, MD, MPH Heightened privacy and confidentiality stakes generate unique anonymity and nondisclosure policies and practices for HIV. AMA J Ethics. 2021;23(5):E376-381. doi: 10.1001/amajethics.2021.376.
Case and Commentary May 2021 How Should Clinicians Respond if Patient HIV Denial Could Exacerbate Racial Health Inequities? Tim Lahey, MD, MMSc Deception’s justifiability might depend on clinicians’ commitment to solidarity and awareness of social determinants of patients’ vulnerability to HIV infection. AMA J Ethics. 2021;23(5):E382-387. doi: 10.1001/amajethics.2021.382.
Case and Commentary May 2021 Should Patients Who Receive Postexposure Prophylaxis After Sexual Assault Be Considered for Preexposure Prophylaxis for HIV? Michela Blain, MD and Julia C. Dombrowski, MD, MPH Patient-centered care means offering potentially beneficial interventions while avoiding retraumatizing a patient. AMA J Ethics. 2021;23(5):E388-393. doi: 10.1001/amajethics.2021.388.
AMA Code Says May 2021 AMA Code of Medical Ethics’ Opinions Related to “Ending the HIV Epidemic: A Plan for America” Robert Dinallo The AMA Code of Medical Ethics offers guidance on HIV screening that expresses respect for patient autonomy while protecting public health. AMA J Ethics. 2021;23(5):E402-404. doi: 10.1001/amajethics.2021.402.
Case and Commentary Apr 2006 Changing the Rules in Times of Crisis: Do Desperate Times Allow Desperate Measures? Mona Loutfy, MD, MPH Clinical case examines the ethics of using an experimental drug in treating a patient who is dying from a SARS-like virus. Virtual Mentor. 2006;8(4):214-218. doi: 10.1001/virtualmentor.2006.8.4.ccas4-0604.